BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7449393)

  • 1. Long-term development of pulmonary hypertension in cryptogenic fibrosing alveolitis.
    Fucík J; Michaljanic A; Jezková L; Jezek V
    Cor Vasa; 1980; 22(4):245-50. PubMed ID: 7449393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of functional tests in cryptogenic fibrosing alveolitis.
    Jezek V; Fucik J; Michaljanic A; Jezkova L
    Bull Eur Physiopathol Respir; 1980; 16(6):711-20. PubMed ID: 7448462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term changes of some ventilatory and respiratory functions in cryptogenic fibrosing alveolitis (author's transl)].
    Fucík J; Ouredník A
    Cas Lek Cesk; 1974 Sep; 113(36):1091-4. PubMed ID: 4410039
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of the functional state of the alveoli and capillary network of the lungs in patients with fibrosing alveolitis].
    Sigaev AT; Ozerova LV; Starilova IP
    Probl Tuberk; 1990; (3):29-32. PubMed ID: 2367505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognosis and development of pulmonary hypertension in idiopathic diffuse interstitial lung fibrosis.
    Jezek V
    G Ital Cardiol; 1984; 14 Suppl 1():39-45. PubMed ID: 6534765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary hypertension in diffuse fibrosing alveolitis].
    Shatalov NN; Guseĭnov SN
    Probl Tuberk; 1984 Dec; (12):29-33. PubMed ID: 6522380
    [No Abstract]   [Full Text] [Related]  

  • 7. [The significance of hypoxemia in the detection of pulmonary hypertension in cryptogenic fibrosing alveolitis].
    Fucík J; Michaljanic A; Jezková L; Krása H; Drechslerová J; Jezek V
    Cas Lek Cesk; 1983 Sep; 122(35):1079-81. PubMed ID: 6627323
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of experimental pulmonary hypertension.
    Herget J; Holusa R; Palecek F
    Physiol Bohemoslov; 1974; 23(6):527-37. PubMed ID: 4280086
    [No Abstract]   [Full Text] [Related]  

  • 9. Myocardial blood flow and right coronary artery haemodynamics in patients with pulmonary hypertension.
    Dubiel JP; Dubiel JS; Horzela T
    Cor Vasa; 1980; 22(4):258-66. PubMed ID: 7449395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognosis of pulmonary hypertension in cryptogenic fibrosing alveolitis of the lung].
    Jezek V; Fucík J
    Vnitr Lek; 1979 Jul; 25(7):635-40. PubMed ID: 494497
    [No Abstract]   [Full Text] [Related]  

  • 11. [Electrocardiographic picture of right ventriclular hypertrophy in cryptogenic fibrous lung alveolitis (comparison with chronic obstructive bronchopulmonary disease)].
    Chlup J; Fucík J; Ouredník A
    Z Kardiol; 1975 Oct; 64(10):959-64. PubMed ID: 129982
    [No Abstract]   [Full Text] [Related]  

  • 12. [Single-lung transplantation for end-stage pulmonary parenchymal diseases with pulmonary hypertension].
    Zhu YH; Chen JY; Zheng MF; Chang S; He YJ; Wang YG
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):401-3. PubMed ID: 17631705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lung function and pulmonary circulation in diffuse fibrosing alveolitis (Hamman-Rich syndrome)].
    Oklek K
    Pol Tyg Lek; 1981 Sep; 36(36):1399-402. PubMed ID: 7329858
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary hypertension in a patient with diffuse fibrosing alveolitis due to rheumatoid arthritis.
    Skwarski K; Zieliński J
    Cor Vasa; 1986; 28(3):206-9. PubMed ID: 3743089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pulmonary hypertension in chronic nonspecific lung diseases].
    Kazanbiev NK
    Sov Med; 1982; (1):58-64. PubMed ID: 6801780
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary hypertension in chronic pulmonary tuberculosis. Part I. Blood pressure in the right ventricle and in the pulmonary artery during rest.
    Jaroslawski M
    Pol Med J; 1968; 7(2):365-71. PubMed ID: 5658052
    [No Abstract]   [Full Text] [Related]  

  • 17. [Markers of thrombophilia in pulmonary fibrosis complicated by pulmonary hypertension].
    Arkhipova DV; Privalova EV; Kozlovskaia LV; Kornev BM; Popova EN; Kraeva VV; Osipenko VI; Bitsadze VO
    Ter Arkh; 2004; 76(3):43-9. PubMed ID: 15108458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vasaprostan treatment of fibrosing alveolitis in patients with pulmonary hypertension].
    Popova EN; Bolevich SB; Litvitskiĭ PF; Arkhipova DV; Osipenko VI; Kogan EA; Kornev BM; Mukhin NA
    Ter Arkh; 2004; 76(8):56-61. PubMed ID: 15471399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical interpretation for the pressure-flow relationships in extrinsic allergic alveolitis and in interstitial lung disease pulmonary hypertension patients. Should we care for the lung, the pulmonary artery pressure or both?].
    Lupi-Herrera E; Santos-Martínez LE; Pulido T; Sandoval J
    Arch Cardiol Mex; 2009; 79(2):91-103. PubMed ID: 19722378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic lupus erythematosus with pulmonary hypertension--normalization of pulmonary artery pressure by long-term administration of beraprost sodium].
    Ubukata M; Motegi M; Sendo Y; Suzuki T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1307-12. PubMed ID: 8583727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.